Loading...

ZIMLAB Zim Laboratories Ltd Product Launches Announcement

Zm L

ZMLB

Zim Laboratories Ltd

(ZIMLAB)

2025 Announcement

Show Summary

Show Summary

Investment Update

Investor Meeting

AGM Announcement

Shareholder Letters

Investor Meet Scheduled

Earnings Call Transcript

Annual General Meeting

Earnings Call Update

Annual Compliance Report

Financial Results Publication

Q4 FY25 Earnings

Management Changes

Earnings Call Scheduled

Investment Update

Cost Auditor Appointment

Compliance Certificate

Collaboration Announcement

Management Change

Equity Investment

Management Changes

Marketing Authorization Gra...

Investment Update

Investor Meeting

Investor Meet Scheduled

Investor Meet Scheduled

Financial Results Published

Earnings Presentation

Marketing Authorization Gra...

Compliance Certificate

Registrar Name Change

Trading Volume Clarification

Investor Meeting Scheduled

Investor Meeting Scheduled

Credit Rating Update

Investor Meeting

New Subsidiary Established

New Subsidiary Incorp.

Earnings Call Transcript

Earnings Call Update

Financial Results Published

Earnings Presentation

Management Changes

Earnings Call Scheduled

Credit Rating Update

SEBI Compliance Update

Investment Update

Equity Investment

Investor Meeting Scheduled

Investor Presentation

Investor Meeting Scheduled

Investors/Analysts Meet

Analyst/Investor Meet

Newspaper Publication

Earnings Presentation

Investment in Subsidiary

Management Change

Marketing Authorization

Dividend Transfer to IEPF

Compliance Certificate Subm...

Investment Update

Investor Meeting

Newspaper Publication

AGM advertisement

Cost Auditor Appointment

Compliance Submission

Earnings Presentation

Financial Investments in Su...

Trading Volume Clarification

Employee Stock Options Grant

Compliance Certificate Subm...

Credit Rating Announcement

Compliance Certificate Subm...

Compliance Certificate Subm...

Investment in ZIMTAS Pty Ltd

Investor Meet Intimation

Meeting Intimation

Investors/Analysts Meet

Investors/Analysts Meet

Earnings Call Recording

Financial Results

Earnings Presentation

Appointment of Secretarial ...

Conference Call

Compliances-Certificate

Investor Meet Schedule

Investor Conferences

Investor Meeting

Investor Conferences

Investors Meet Scheduled

Q2 & H1FY24 Earnings Confer...

Conference Call

Newspaper Publication

Earnings Presentation

Incorporation of Step-Down ...

Compliance Certificate Subm...

Investors/Analysts Meet

Financial Statements

Financial Statements

Financial Statements

Financial Statements

Equity, Debt, VC, Private E...

Asset Acquisitions

Analyst Meeting

AGM Announcement

AGM Announcements

Investor Meetings

Equity Carve-outs

Credit rating assigned by r...

Investor Meetings

Earnings Conference Call

Annual Secretarial Complian...

Financial Results Publication

Related Party Transactions

External Links:

Data:

Zim Laboratories and Neuraxpharm received marketing authorization for Buprenorphine Sublingual Film in Europe, a treatment for opioid drug dependence, as the European market for Buprenorphine reached USD 1.3 billion in 2023.

AI Assistant

Zim Laboratories Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.